Our top pick for
Building a portfolio
Encompass Health Corporation is a medical care facilities business based in the US. Encompass Health Corporation shares (EHC) are listed on the NYSE and all prices are listed in US Dollars. Encompass Health Corporation employs 27,894 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$58.06 - $89.68|
|50-day moving average||$82.63|
|200-day moving average||$79.33|
|Wall St. target price||$97.27|
|Dividend yield||$1.12 (1.31%)|
|Earnings per share (TTM)||$3.05|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Encompass Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Encompass Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Encompass Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Encompass Health Corporation shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Encompass Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $919.2 million.
The EBITDA is a measure of a Encompass Health Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.7 billion|
|Operating margin TTM||14.33%|
|Gross profit TTM||$1.8 billion|
|Return on assets TTM||6.63%|
|Return on equity TTM||20.11%|
|Market capitalisation||$8.5 billion|
TTM: trailing 12 months
There are currently 2.4 million Encompass Health Corporation shares held short by investors – that's known as Encompass Health Corporation's "short interest". This figure is 15.2% up from 2.1 million last month.
There are a few different ways that this level of interest in shorting Encompass Health Corporation shares can be evaluated.
Encompass Health Corporation's "short interest ratio" (SIR) is the quantity of Encompass Health Corporation shares currently shorted divided by the average quantity of Encompass Health Corporation shares traded daily (recently around 603064.4278607). Encompass Health Corporation's SIR currently stands at 4.02. In other words for every 100,000 Encompass Health Corporation shares traded daily on the market, roughly 4020 shares are currently held short.
However Encompass Health Corporation's short interest can also be evaluated against the total number of Encompass Health Corporation shares, or, against the total number of tradable Encompass Health Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Encompass Health Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Encompass Health Corporation shares in existence, roughly 20 shares are currently held short) or 0.032% of the tradable shares (for every 100,000 tradable Encompass Health Corporation shares, roughly 32 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Encompass Health Corporation.
Find out more about how you can short Encompass Health Corporation stock.
Dividend payout ratio: 28.43% of net profits
Recently Encompass Health Corporation has paid out, on average, around 28.43% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.31% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Encompass Health Corporation shareholders could enjoy a 1.31% return on their shares, in the form of dividend payments. In Encompass Health Corporation's case, that would currently equate to about $1.12 per share.
While Encompass Health Corporation's payout ratio might seem fairly standard, it's worth remembering that Encompass Health Corporation may be investing much of the rest of its net profits in future growth.
Encompass Health Corporation's most recent dividend payout was on 14 April 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 March 2021 (the "ex-dividend date").
Encompass Health Corporation's shares were split on a 1:5 basis on 25 October 2006. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Encompass Health Corporation shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Encompass Health Corporation shares which in turn could have impacted Encompass Health Corporation's share price.
Over the last 12 months, Encompass Health Corporation's shares have ranged in value from as little as $58.061 up to $89.68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Encompass Health Corporation's is 1.1456. This would suggest that Encompass Health Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of March 16, 2021, it operated 137 hospitals, 241 home health locations, and 82 hospice locations in 39 states and Puerto Rico.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.